BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
1081 results:

  • 1. Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing.
    Lahey KC; Varsanyi C; Wang Z; Aquib A; Gadiyar V; Rodrigues AA; Pulica R; Desind S; Davra V; Calianese DC; Liu D; Cho JH; Kotenko SV; De Lorenzo MS; Birge RB
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673989
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Novel PIKfyve/Tubulin Dual-target Inhibitor as a Promising Therapeutic Strategy for B-cell Acute Lymphoblastic Leukemia.
    Lu Z; Lai Q; Li ZF; Zhong MY; Jiang YL; Feng LY; Zha J; Yao JW; Li Y; Deng XM; Xu B
    Curr Med Sci; 2024 Apr; 44(2):298-308. PubMed ID: 38619682
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells.
    Liu Y; Zhang S; Tan Y
    Hematology; 2024 Dec; 29(1):2337307. PubMed ID: 38573223
    [No Abstract]    [Full Text] [Related]  

  • 4. Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma.
    Hoang NM; Liu Y; Bates PD; Heaton AR; Lopez AF; Liu P; Zhu F; Chen R; Kondapelli A; Zhang X; Selberg PE; Ngo VN; Skala MC; Capitini CM; Rui L
    Cell Rep Med; 2024 Apr; 5(4):101484. PubMed ID: 38554704
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2
    Ichikawa T; Suekane A; Nakahata S; Iha H; Shimoda K; Murakami T; Morishita K
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474089
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Renin-Angiotensin System Inhibitors Suppress the Growth of Leukemia Cells.
    Itoh M; Sasaki S; Tohda S
    Anticancer Res; 2024 Mar; 44(3):1183-1192. PubMed ID: 38423665
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effect of Ferroptosis Inducers and Inhibitors on Cell Proliferation in Acute Leukemia.
    Kumada H; Itoh M; Tohda S
    Anticancer Res; 2024 Mar; 44(3):1003-1010. PubMed ID: 38423654
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Plasmablastic lymphoma: current knowledge and future directions.
    Li JW; Peng HL; Zhou XY; Wang JJ
    Front Immunol; 2024; 15():1354604. PubMed ID: 38415257
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
    Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
    Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High-grade B-cell lymphoma, not otherwise specified, presenting as primary peritoneal lymphomatosis and successfully treated with dose-adjusted EPOCH-R.
    Fujimi A; Nagamachi Y; Yamauchi N; Onoyama N; Hayasaka N; Matsuno T; Koike K; Goto Y; Ihara K; Kato J; Nishisato T; Kawase H; Yano T; Kanaseki T; Sugita S; Kobune M
    J Clin Exp Hematop; 2024 Mar; 64(1):37-44. PubMed ID: 38281744
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Combinatorial targeting of telomerase and DNA-PK induces synergistic apoptotic effects against Pre-B acute lymphoblastic leukemia cells.
    Katoueezadeh M; Maleki P; Torabizadeh SA; Farsinejad A; Khalilabadi RM; Valandani HM; Nurain IO; Ashoub MH; Fatemi A
    Mol Biol Rep; 2024 Jan; 51(1):163. PubMed ID: 38252348
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. myc rearrangements in HIV-associated large B-cell lymphomas: EUROmyc, a European retrospective study.
    Pagani C; Rusconi C; Dalla Pria A; Ravano E; Schommers P; Bastos-Oreiro M; Verga L; Gini G; Spina M; Arcaini L; Steffanoni S; Dalu D; Crucitti L; Lorenzi L; Balzarini P; Cattaneo C; Bongiovanni L; Rosenwald A; Facchetti F; Bower M; Ferreri AJM; Rossi G; Tucci A; Re A
    Blood Adv; 2024 Feb; 8(4):968-977. PubMed ID: 38207206
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter.
    Lai J; Shang C; Chen W; Izevbaye I; Chu MP; Sandhu I; Brandwein J; Lai R; Wang P
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203669
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age.
    Seaton G; Smith H; Brancale A; Westwell AD; Clarkson R
    Mol Cancer; 2024 Jan; 23(1):7. PubMed ID: 38195591
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Clinical study of mature B-cell lymphoma in 11 children with chromosome 11 long-arm abnormalities].
    Zhang N; Duan YL; Zhou CJ; Jin L; Yang J; Huang S; Zhang M; Li N
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):924-929. PubMed ID: 38185522
    [No Abstract]    [Full Text] [Related]  

  • 16. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse.
    Yan X; Chen B; Jing H; Yang Z; Zhang T; Lin Y; Shi J
    J Hematop; 2023 Dec; 16(4):235-240. PubMed ID: 38175437
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Monomorphic epitheliotropic intestinal T-cell lymphoma involving the central nervous system: a rare case report with comprehensive autopsy neuropathological examinations.
    Talabong DJA; Laguerre E; Chen NN; Zeng J
    J Hematop; 2023 Sep; 16(3):155-160. PubMed ID: 38175405
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma.
    Wang Y; Shi Q; Shi ZY; Tian S; Zhang MC; Shen R; Fu D; Dong L; Yi HM; Ouyang BS; Mu RJ; Cheng S; Wang L; Xu PP; Zhao WL
    Blood Adv; 2024 Apr; 8(7):1587-1599. PubMed ID: 38170757
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis.
    Ren W; Wan H; Own SA; Berglund M; Wang X; Yang M; Li X; Liu D; Ye X; Sonnevi K; Enblad G; Amini RM; Sander B; Wu K; Zhang H; Wahlin BE; Smedby KE; Pan-Hammarström Q
    Leukemia; 2024 Mar; 38(3):610-620. PubMed ID: 38158444
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The significance of concurrent myc and BCL2 expression in Egyptian patients with diffuse large B-cell NHL.
    Abdelhamid TM; Gaber AA; Abdelfattah RM; Algamal DA; Hamdy O; Mohamed G
    Pathol Res Pract; 2024 Jan; 253():154973. PubMed ID: 38101156
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 55.